Form 4 holding
Director
Replimune Group, Inc.
- Security class
- Common Stock
- Shares / value
- 1,821,872
- Estimated value
- $11,787,512
- Report date
- 16 May 2024
- Price
- $6.47
- Ownership
- Direct
Robert Coffin
Insider Reports History
- Reporting-owner location
- Woburn, MA
- Latest reporting-owner signature
- /s/ Shawn Glidden, attorney-in-fact
- Transaction source note
- Rows are grouped by transaction date from the original SEC filing. Open the aggregated insider activity page to review issuer-level activity across dates.
Identity
Names, identifiers, and filing context for this profile.
1 identity field
SEC source record
Original filing metadata and source links for verification.
1 source field
Source evidence
Original filing metadata and source links for verification.
1 source field
Reported holdings for Robert Coffin
Insider Reports Filed by Robert Coffin
4
REPL
Replimune Group, Inc.
- Report period
- 16 May 2024
- Transactions
- 1
- Transaction value
- -$74,172
- Accepted by SEC
- 20 May 2024, 20:02
- Role
- Director
- Next action
- Open filing details
4
REPL
Replimune Group, Inc.
- Report period
- 16 May 2023
- Transactions
- 1
- Transaction value
- -$141,891
- Accepted by SEC
- 18 May 2023, 20:35
- Role
- President & Chief R&D Officer, Director
- Next action
- Open filing details
4
REPL
Replimune Group, Inc.
- Report period
- 01 Apr 2023
- Transactions
- 2
- Transaction value
- $0
- Accepted by SEC
- 04 Apr 2023, 20:00
- Role
- President & Chief R&D Officer, Director
- Next action
- Open filing details
4
REPL
Replimune Group, Inc.
- Report period
- 16 May 2022
- Transactions
- 1
- Transaction value
- -$83,703
- Accepted by SEC
- 18 May 2022, 19:01
- Role
- President & Chief R&D Officer, Director
- Next action
- Open filing details
4
REPL
Replimune Group, Inc.
- Report period
- 01 Apr 2022
- Transactions
- 2
- Transaction value
- $0
- Accepted by SEC
- 05 Apr 2022, 16:18
- Role
- President & Chief R&D Officer, Director
- Next action
- Open filing details
4
REPL
Replimune Group, Inc.
- Report period
- 02 Jul 2021
- Transactions
- 1
- Transaction value
- -$312,712
- Accepted by SEC
- 07 Jul 2021, 21:01
- Role
- President & Chief R&D Officer, Director
- Next action
- Open filing details
4
REPL
Replimune Group, Inc.
- Report period
- 28 Jun 2021
- Transactions
- 2
- Transaction value
- -$1,501,288
- Accepted by SEC
- 30 Jun 2021, 21:00
- Role
- President & Chief R&D Officer, Director
- Next action
- Open filing details